Covaxin 77.8% Effective In Phase 3 Trial Data: Sources

Covaxin 77.8% effective in phase 3 trial data in review by expert committee: sources

Similar Articles

Comments

spot_img

Most Popular

You cannot copy content of this page

In Order to Strengthen Democracy, Citizens Should Bear the Cost of Impartial Journalism. Join 1-Rupee Campaign